AU781842B2 - Use of growth hormone (hGH) for the treatment of sexual functional disturbances - Google Patents
Use of growth hormone (hGH) for the treatment of sexual functional disturbances Download PDFInfo
- Publication number
- AU781842B2 AU781842B2 AU62635/00A AU6263500A AU781842B2 AU 781842 B2 AU781842 B2 AU 781842B2 AU 62635/00 A AU62635/00 A AU 62635/00A AU 6263500 A AU6263500 A AU 6263500A AU 781842 B2 AU781842 B2 AU 781842B2
- Authority
- AU
- Australia
- Prior art keywords
- substances
- hgh
- growth hormone
- sexual
- stimulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19927678 | 1999-06-17 | ||
DE19927678 | 1999-06-17 | ||
PCT/EP2000/005517 WO2000078328A2 (de) | 1999-06-17 | 2000-06-15 | VERWENDUNG VON WACHSTUMSHORMON (hGH) ZUR THERAPIE SEXUELLER FUNKTIONSSTÖRUNGEN |
Publications (2)
Publication Number | Publication Date |
---|---|
AU6263500A AU6263500A (en) | 2001-01-09 |
AU781842B2 true AU781842B2 (en) | 2005-06-16 |
Family
ID=7911578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU62635/00A Ceased AU781842B2 (en) | 1999-06-17 | 2000-06-15 | Use of growth hormone (hGH) for the treatment of sexual functional disturbances |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1207902A2 (ja) |
JP (1) | JP2003502379A (ja) |
AU (1) | AU781842B2 (ja) |
CA (1) | CA2377339A1 (ja) |
NZ (1) | NZ516223A (ja) |
WO (1) | WO2000078328A2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120264722A1 (en) * | 2004-05-11 | 2012-10-18 | Emotional Brain B.V. | Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7054945B2 (en) * | 2001-04-09 | 2006-05-30 | Nokia Corporation | Technique for providing announcements in mobile-originated calls |
EP1790343A1 (en) | 2005-11-11 | 2007-05-30 | Emotional Brain B.V. | Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction |
EP1925307A1 (en) | 2006-11-03 | 2008-05-28 | Emotional Brain B.V. | Use of 3-alpha-androstanediol in the treatment of sexual dysfunction |
CA2643529C (en) * | 2008-11-06 | 2019-05-21 | Kenneth W. Adams | Method and composition for enhancement of male erectile function |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998042631A1 (en) * | 1997-03-21 | 1998-10-01 | W.R. Grace & Co.-Conn. | Additive for production of highly workable mortar cement |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5916569A (en) * | 1997-03-26 | 1999-06-29 | E. Martin Spencer | Human erectile dysfunction and methods of treatment |
-
2000
- 2000-06-15 CA CA002377339A patent/CA2377339A1/en not_active Abandoned
- 2000-06-15 AU AU62635/00A patent/AU781842B2/en not_active Ceased
- 2000-06-15 EP EP00949187A patent/EP1207902A2/de not_active Withdrawn
- 2000-06-15 JP JP2001504391A patent/JP2003502379A/ja active Pending
- 2000-06-15 WO PCT/EP2000/005517 patent/WO2000078328A2/de not_active Application Discontinuation
- 2000-06-15 NZ NZ516223A patent/NZ516223A/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998042631A1 (en) * | 1997-03-21 | 1998-10-01 | W.R. Grace & Co.-Conn. | Additive for production of highly workable mortar cement |
Non-Patent Citations (1)
Title |
---|
JUNG-GYUNG WOO ET AL, JOURNAL UROLOGY 1998, 160(5) 1899-1904 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120264722A1 (en) * | 2004-05-11 | 2012-10-18 | Emotional Brain B.V. | Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction |
US9192669B2 (en) * | 2004-05-11 | 2015-11-24 | Eb Ip Lybrido B.V. | Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction |
Also Published As
Publication number | Publication date |
---|---|
CA2377339A1 (en) | 2000-12-28 |
WO2000078328A3 (de) | 2002-02-28 |
WO2000078328A2 (de) | 2000-12-28 |
AU6263500A (en) | 2001-01-09 |
JP2003502379A (ja) | 2003-01-21 |
NZ516223A (en) | 2003-08-29 |
EP1207902A2 (de) | 2002-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3255289B2 (ja) | アルファー―2―アドレナリン作動薬及び成長ホルモン放出ペプチドによる肥満症の治療 | |
Marshall et al. | GnRH pulses--the regulators of human reproduction. | |
Lee et al. | C-type natriuretic peptide inhibits ANP secretion and atrial dynamics in perfused atria: NPR-B-cGMP signaling | |
LANCRANJAN et al. | Effect of 1–5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man | |
US6338862B1 (en) | Composition and method of use in treating sexual dysfunction using cGMP-specific phosphodiesterase type 5 inhibitors | |
CA2230968A1 (en) | Method of treating insulin resistance | |
Van de Waal | Induction of testicular growth and spermatogenesis by pulsatile, intravenous administration of gonadotrophin‐releasing hormone in patients with hypogonadotrophic hypogonadism | |
US4654324A (en) | Human proinsulin pharmaceutical formulations | |
Lippert et al. | Effects of oxytocin outside pregnancy | |
Kannan | The pituitary gland | |
US4652547A (en) | Pharmaceutical formulations comprising human insulin and human proinsulin | |
AU781842B2 (en) | Use of growth hormone (hGH) for the treatment of sexual functional disturbances | |
Invitti et al. | TREATMENT OF CUSHING'S SYNDROME WITH THE LONG‐ACTING SOMATOSTATIN ANALOGUE SMS 201‐995 (SANDOSTATIN) | |
Veldhuis et al. | Divergent influences of calcium ions on releasing factor-stimulated anterior pituitary hormone secretion in normal man | |
JP2007508381A (ja) | 勃起障害治療のための方法および組成物 | |
Kasai et al. | Glycine stimulates growth hormone release in man | |
RU2663455C2 (ru) | КОМБИНАЦИЯ АНАЛОГОВ СОМАТОСТАТИНА С ИНГИБИТОРАМИ 11β- ГИДРОКСИЛАЗЫ | |
Dimaraki et al. | Generation of growth hormone pulsatility in women: evidence against somatostatin withdrawal as pulse initiator | |
CA2099476A1 (en) | Medicaments comprising glicentin as active ingredient | |
HRP20040070A2 (en) | Use of lh in controlled ovarian hyperstimulation | |
Lundberg | Blood levels of FSH, LH, TSH, and GH in parkinsonian patients before and during L‐dopa treatment | |
Zgliczyński et al. | The effect of D-Trp6-LRH upon secretion of gonadotrophin–a possible therapeutic application in anorexia nervosa | |
US20050176829A1 (en) | Methods for treating hypothyroidism | |
Jauch et al. | Dose-dependent effects of Human-Growth-Hormone (rHGH) on post-operative substrate metabolism | |
Saito et al. | Effects of growth hormone dose after major abdominal operation: a randomized, prospective, multicenter trial |